Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 171

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 171
---
 no shareholding qualification for directors, although a shareholding qualification for directors may be fixed by our shareholders by ordinary resolution.

<div align='center'>95</div>

Insider Participation Concerning Executive Compensation

Our board of directors, which currently consists of Ka Lun To and Shing Hei Lee and will also consist of three independent directors whose appointments will be effective as of the effectiveness of the registration statement of which this prospectus forms a part, is making all determinations regarding executive officer compensation from the time the Company first entered into employment agreements with executive officers up until the time where the three independent directors will be installed.

Committees of the Board of Directors

We will establish three committees under the board of directors immediately upon the effectiveness of the registration statement of which this prospectus forms a part: an audit committee, a compensation committee and a nominating and corporate governance committee. Even though we are exempted from corporate governance standards because we are a foreign private issuer, we have voluntarily adopted a charter for each of the three committees. Each committee’s members and functions are described below.

Audit Committee. Our audit committee will consist of Kenrick B Toussaint, Chun Fai Fong, and Bin Zhou. Kenrick B Toussaint will be the chairman of our audit committee. We have determined that Kenrick B Toussaint, Chun Fai Fong, and Bin Zhou will satisfy the “independence” requirements of Section 5605(a)(2) of the Nasdaq Listing Rules and Rule 10A-3 under the Exchange Act. Our board also has determined that Kenrick B Toussaint qualifies as an audit committee financial expert within the meaning of the SEC rules or possesses financial sophistication within the meaning of the Nasdaq Listing Rules. The audit committee will oversee our accounting and financial reporting processes and the audits of the financial statements of our company. The audit committee will be responsible for, among other things:

| ● | appointing                                                                                  
 the independent auditors and pre-approving all auditing and non-auditing services permitted 
 to be performed by the independent auditors;                                                |

| ● | reviewing                                                                                   
 with the independent auditors any audit problems or difficulties and management’s response; |

| ● | discussing                                                                            
 the annual audited financial statements with management and the independent auditors; |

| ● | reviewing                                                                                     
 the adequacy and effectiveness of our accounting and internal control policies and procedures 
 and any steps taken to monitor and control major financial risk exposures;                    |

| ● | reviewing                                              
 and approving all proposed